Overview

Cell Culture Market Introduction 

The Cell Culture Market is estimated to value over USD 25.4 billion and register a CAGR of over 10.8% from the forecast period 2020 to 2027.
Increasing awareness about the benefits of culture-based vaccines and rising adoption for single-use technologies are the major factors driving the market growth. Growing demand for monoclonal antibodies and rising investments for cell-based research is augmenting the market. Factors such as increasing attention towards personalized medicine and the development of many biopharmaceutical products such as therapeutic and vaccines are driving the market. 

Cell Culture Market Overview
The market is classified into by product, application, end-user, and region. Based on type, the cell structure is segmented into sera, media & reagents, vessels and bioreactor accessories. Sera, media & reagents are expected to dominate the growth of the market. 
Reagents such as antibiotics are effective towards contamination and possible toxicity and contamination detection kits are more efficient and faster than other direct culture methods. Serum-free media eliminates the risk of contamination posed by viruses. Owing to these factors, there has been a spike in the demand of sera, media and reagents thus propelling the market.
In terms of application, biopharmaceutical production is expected to hold a vast share of the market. The increasing demand for therapeutic proteins is driving the demand for biopharmaceutical production thus positively influencing the market. Rising incidences of diseases have led to more demand for vaccine production which expands the market. The increasing demand for single-use technologies and growing government approvals towards cell culture-based vaccines are fueling the market. 

In terms of regions, North America is the global leader of the market. Government and private enterprises rising interest in vaccines related to cell culture and higher investments in cell-based research are driving the growth of the market in the region. Strong government support for R&D activities is boosting the presence of the market in the region. In terms of end-users, pharmaceutical and biotechnological companies are the front runners due to their large consumption of cell culture for bioproduction. Expansion of major biopharmaceutical players has also bolstered the market. Asia-Pacific region is predicted to be a lucrative region owing to increasing government support of emerging economies like India and China for biotech research. Large population size and government policies favoring biopharmaceutical manufacturing have lured the prominent players to penetrate into the region.
Prominent players of the market are Lonza, Becton, Dickinson, and Company, Merck KGaA, Corning Incorporated, CellGenix GmbH, Eppendorf AG, PromoCell GmbH, GE Healthcare, HiMedia Laboratories, Sartorius AG, InvivoGen and Irvine Scientific.

Competitive Landscape:
●     Thermo Fisher Scientific in 2019 invested USD 150 million to expand its capacity of lyophilized product development and sterile liquids. Their centers across Italy and the US will have aseptic filling lines alongside isolator technology which will help in strengthening the company's customer base worldwide
●     Merck in 2018 opened its BioReliance biosafety testing lab in Singapore. Their new lab will offer critical testing services which would further augment the market
●     Fujifilm in 2018, acquired IS JAPAN CO., LTD, and Irvine Scientific. The move helped Fujifilm enhance regenerative medicine and reagent business, hence bolstering the company's foothold in the market
 
FutureWise Key Takeaways
●     According to our industry experts, single-use bioreactors are expected to witness immense demand owing to the rising adoption of single-use technologies. Single-use technologies offer benefits such as low price and low contamination risk. In addition, the demand for mAbs is also fueling the demand of single-use bioreactors thus propelling the market
●     Europe is expected to be a high growth profit region owing to the growing support of private investors and the government for R&D activity in countries like Germany and France. Expansion of the life science industry in the UK is also positively influencing the market
 
Cell Culture Market Segmentation :
By Product 
●    Consumables 

• Sera, Media and Reagents
• Vessels
• Bioreactor Accessories 

●    Equipment 

• Supporting Equipment 
• Bioreactors 
• Storage Equipment 

By Application 
●     Biopharmaceutical Production 
●     Diagnostics 
●     Drug Screening and Development
●     Stem Cell Research 
●     Tissue Engineering & Regenerative Medicine
 
By End-User 
●     Pharmaceutical & Biotechnology Companies
●     Hospitals and Diagnostic Laboratories 
●     Research Institutes
 
By Region
●     North America
●     Europe
●     Asia Pacific
●     Latin America
●     Rest of the World
 
Objectives of the Study:
• To provide with an exhaustive analysis on the global cell culture market by product, by application, by end-user, and by region
• To cater to comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America and the rest of the world
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers, and expansions
• Profiling of companies to evaluate their market shares, strategies, financial and core competencies
 

Table of Contents

1 Introduction 

    1.1 Objectives of the Study 

    1.2 Market Definition 

    1.3 Market Scope 

           1.3.1 Markets Covered

           1.3.2 Years Considered for the Study

    1.4 Currency 

    1.5 Limitation 

    1.6 Stakeholders 

 

2 Research Methodology 

    2.1 Research Data 

    2.2 Secondary Data 

           2.2.1 Secondary Source

    2.3 Primary Data 

           2.3.1 Key Data From Primary Sources

    2.4 Market Size Estimation 

    2.5 Market Breakdown and Data Triangulation 

    2.6 Assumptions for the Study 

 

3 Executive Summary 

 

4 Premium Insights 

    4.1 Cell Culture: Market Overview 

    4.2 Asia Pacific: Market Share, By End User and Country (2020) 

    4.3 Cell Culture Sera, Media, & Reagents Market, By Type (USD Billion) 

    4.4 Market, By Application, 2020 vs 2027 (USD Billion) 

    4.5 Market, By Product, 2020 vs 2027 (USD Billion) 

    4.6 Geographical Snapshot of the Market 

 

5 Market Overview 

    5.1 Introduction 

    5.2 Market Dynamics 

           5.2.1 Market Drivers

                    5.2.1.1 Growing Awareness About the Benefits of Cell Culture-Based Vaccines

                    5.2.1.2 Increasing Demand for Monoclonal Antibodies

                    5.2.1.3 Funding for Cell-Based Research

                    5.2.1.4 Growing Preference for Single-Use Technologies

                    5.2.1.5 Launch of Advanced Cell Culture Products

                    5.2.1.6 Growing Focus on Personalized Medicine

           5.2.2 Market Restraints

                    5.2.2.1 High Cost of Cell Biology Research

                    5.2.2.2 Lack of Infrastructure for Cell-Based Research in Emerging Economies

           5.2.3 Market Opportunities

                    5.2.3.1 Growing Demand for 3D Cell Culture

                    5.2.3.2 Increased Risk of Pandemics and Communicable Diseases

                    5.2.3.3 Emerging Economies

 

6 Cell Culture Market, By Product     

6.1 Introduction 

    6.2 Consumables 

           6.2.1 Sera, Media, and Reagents

                    6.2.1.1 Media

                               6.2.1.1.1 Serum-Free Media

                                             6.2.1.1.1.1 Lack of Sera Eliminates the Risk of Contamination By Viruses

                               6.2.1.1.2 Classical Media & Salts

                                             6.2.1.1.2.1 Classical Media is Commonly Used in Diagnostics and Manufacturing

                               6.2.1.1.3 Stem Cell Culture Media

                                             6.2.1.1.3.1 Stem Cell Culture Media Will Witness the Highest Growth in the APAC Market

                               6.2.1.1.4 Specialty Media

                                             6.2.1.1.4.1 Specialty Media is Suitable for Specific, Selective Cell Types

                    6.2.1.2 Reagents

                               6.2.1.2.1 Supplements & Growth Factors

                                             6.2.1.2.1.1 Supplements Such as Amino Acids Play A Key Role in Inducing Cell Growth

                               6.2.1.2.2 Buffers & Chemicals

                                             6.2.1.2.2.1 Chemical Buffers are Widely Used, But are Expensive and Can Be Toxic

                               6.2.1.2.3 Cell Dissociation Reagents

                                             6.2.1.2.3.1 Dissociation Reagents Can Be Enzymatic Or Non-Enzymatic

                               6.2.1.2.4 Balanced Salt Solutions

                                             6.2.1.2.4.1 Salt Solutions Find Wide Applications in Life Sciences

                               6.2.1.2.5 Attachment & Matrix Factors

                                             6.2.1.2.5.1 Development of Cells is Dependent on Attachment Factors

                               6.2.1.2.6 Antibiotics/Antimycotics

                                             6.2.1.2.6.1 Possibility of Toxicity and Contamination Risks Make Long-Term Use of Antibiotics/Antimycotics Conditional

                               6.2.1.2.7 Contamination Detection Kits

                                             6.2.1.2.7.1 Kits Provide Results in Hours, Much Faster Than Direct Culture Methods

                               6.2.1.2.8 Cryoprotective Reagents

                                             6.2.1.2.8.1 Inorganic Expansions are A Favored Strategy for Companies in This Market

                               6.2.1.2.9 Other Cell Culture Reagents

                    6.2.1.3 Sera

                               6.2.1.3.1 Fetal Bovine Sera

                                             6.2.1.3.1.1 Use of Fbs is Associated With Ethical Issues

                               6.2.1.3.2 Adult Bovine Sera

                                             6.2.1.3.2.1 ABS is Used as A Biochemical Agent in Ivd

                               6.2.1.3.3 Other Animal Sera

           6.2.2 Vessels

                    6.2.2.1 Roller/Roux Bottles

                               6.2.2.1.1 Roller Bottles Offer an Economical Means of Cultivating Large Cell Volumes

                    6.2.2.2 Cell Factory Systems/Cell Stacks

                               6.2.2.2.1 Cell Stacks Require Special Handling Equipment and Skilled Expertise

                    6.2.2.3 Multiwell Plates

                               6.2.2.3.1 Larger Well Formats Allow for Greater Culture Volumes

                    6.2.2.4 Flasks

                               6.2.2.4.1 Disposable Flasks are in Greater Demand Among End Users

                    6.2.2.5 Petri Dishes

                               6.2.2.5.1 Wide Usage of Petri Dishes is Attributed to Their Ease of Use

           6.2.3 Bioreactor Accessories

    6.3 Equipment 

           6.3.1 Supporting Equipment

                    6.3.1.1 Filtration Systems

                               6.3.1.1.1 Growing Research in Cell Biology is A Key Factor Driving Market Growth

                    6.3.1.2 Cell Counters

                               6.3.1.2.1 Automated Cell Counters are Witnessing Growing Demand

                    6.3.1.3 Carbon Dioxide Incubators

                               6.3.1.3.1 Incubators Provide Control Over Atmospheric Conditions for Best Effect

                    6.3.1.4 Centrifuges

                               6.3.1.4.1 Technological Advances have Enabled the Development of Faster, More Effective Centrifuges

                    6.3.1.5 Autoclaves

                               6.3.1.5.1 Autoclaves Sterilize Equipment and Supplies for Use

                    6.3.1.6 Microscopes

                               6.3.1.6.1 Inverted Microscopes are Widely Used in Cell Culture Processes

                    6.3.1.7 Biosafety Cabinets

                               6.3.1.7.1 Cabinets are Classified Into Three Classes Based on Protection Offered

                    6.3.1.8 Other Supporting Equipment

           6.3.2 Bioreactors

                    6.3.2.1 Conventional Bioreactors

                               6.3.2.1.1 Conventional Bioreactors Hold the Largest Share of the Bioreactors Market

                    6.3.2.2 Single-Use Bioreactors

                               6.3.2.2.1 Convenience, Ease of Use, and Flexibility are Driving Demand for Single-Use Bioreactors

           6.3.3 Storage Equipment

                    6.3.3.1 Refrigerators & Freezers

                               6.3.3.1.1 Refrigerators & Freezers are Used for Both Short and Long-Term Storage

                    6.3.3.2 Cryostorage Systems

                               6.3.3.2.1 Benefits of Long-Term Preservation of Cell Cultures are Driving Market Growth

 

7 Cell Culture Market, By Application 

    7.1 Introduction 

    7.2 Biopharmaceutical Production 

           7.2.1 Therapeutic Proteins

                    7.2.1.1 Growing Applications of Recombinant Proteins to Drive This Segment

           7.2.2 Vaccine Production

                    7.2.2.1 Rising Incidence of Disease Outbreaks to Drive the Market for Vaccine Production

    7.3 Diagnostics 

           7.3.1 Cell Cultures are Used in the Diagnosis of Viral Diseases

    7.4 Drug Screening and Development 

    7.5 Stem Cell Research 

           7.5.1 Stringent Regulations to Conduct Clinical Trials for New Stem Cell-Based Therapies on Human Subjects is Restraining the Growth of This Segment

    7.6 Tissue Engineering & Regenerative Medicine 

    7.7 Other Applications

 

8 Cell Culture Market, By End User 

    8.1 Introduction 

    8.2 Pharmaceutical & Biotechnology Companies 

           8.2.1 Increasing Use of Single-Use Technologies is Driving the Growth of the Market for This Segment

    8.3 Hospitals and Diagnostic Laboratories 

           8.3.1 Increasing Awareness for the Diagnosis of Various Diseases to Drive This Segment

    8.4 Research Institutes 

           8.4.1 Increasing Government Funding for Research Projects and High Prevalence of Cancer to Drive the Market for Research Institutes

    8.5 Cell Banks 

           8.5.1 Increasing Awareness of Preserving Stem Cells to Drive This Segment

 

9 Cell Culture Market, By Region 

    9.1 Introduction 

    9.2 North America 

           9.2.1 US

                    9.2.1.1 US to Dominate the North American Market

           9.2.2 Canada

                    9.2.2.1 Advancement in the Field of Regenerative Medicine to Drive the Market in Canada

    9.3 Europe 

           9.3.1 Germany

                    9.3.1.1 Increasing Investment By Various Key Players and Growing Funding From Government Organizations to Drive the Market

           9.3.2 France

                    9.3.2.1 Support From Government and Private Investors to Drive the Market for Cell Culture in France

           9.3.3 UK

                    9.3.3.1 Growth in the Life Science Industry to Drive the Market for Cell Culture in the UK

           9.3.4 Italy

                    9.3.4.1 Increasing Number of Cell Biology Seminars and Conferences to Fuel the Adoption of Cell Culture Products

           9.3.5 Spain

                    9.3.5.1 Increasing Funding From Private and Public Organizations to Aid Market Growth

           9.3.6 RoE

    9.4 Asia Pacific 

           9.4.1 Japan

                    9.4.1.1 Strategic Developments By Companies to Drive the Market for Cell Culture in Japan

           9.4.2 China

                    9.4.2.1 Government Initiatives and Strategic Initiatives By Key Players to Strengthen the Biotechnology Industry in China

           9.4.3 India

                    9.4.3.1 Growth Initiatives to Promote Life Science Industry to Drive the Market for Cell Culture in India

           9.4.4 RoAPAC

    9.5 Rest of the World (RoW) 

10 Competitive Landscape 

     10.1 Overview 

     10.2 Market Share Analysis, 2018 

     10.3 Competitive Scenario 

             10.3.1 Partnerships, Agreements, and Collaborations (2016–2020)

             10.3.2 Product Launches (2016–2020)

             10.3.3 Expansions (2016–2020)

             10.3.4 Acquisitions (2016–2020)

     10.4 Competitive Leadership Mapping (2020) 

             10.4.1 Vendor Inclusion Criteria

             10.4.2 Vanguards

             10.4.3 Innovators

             10.4.4 Dynamic Players

             10.4.5 Emerging Players

11 Company Profiles 

(Business Overview, Products Offered, Recent Developments, FutureWise Insights)*

     11.1 Becton, Dickinson and Company 

     11.2 Cellgenix 

     11.3 Corning 

     11.4 Danaher 

     11.5 Eppendorf 

     11.6 Fujifilm Irvine Scientific (Acquired By Fujifilm Corporation) 

     11.7 GE Healthcare (A Subsidiary of General Electric Company) 

     11.8 Hi-Media Laboratories 

     11.9 Invivogen 

     11.10 Lonza Group AG 

     11.11 Merck KGaA 

     11.12 Miltenyi Biotec 

     11.13 Promocell 

     11.14 Sartorius AG 

     11.15 Thermo Fisher Scientific 

 

12 Research Finding and Conclusion 

13 Appendix 

13.1 Research Methodology 

13.2 Research Data Source 

 

Tables

Figures